Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6126)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lamarca A, Feliu J. Pancreatic biomarkers: Could they be the answer? World J Gastroenterol 2014; 20(24): 7819-7829 [PMID: 24976720 DOI: 10.3748/wjg.v20.i24.7819] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i24/7819.htm |
| Number | Citing Articles |
| 1 |
J. Gallego, C. López, R. Pazo-Cid, F. López-Ríos, A. Carrato. Biomarkers in pancreatic ductal adenocarcinoma. Clinical and Translational Oncology 2017; 19(12): 1430 doi: 10.1007/s12094-017-1691-5
|
| 2 |
Chunyuan Cen, Liying Liu, Xin Li, Ailan Wu, Huan Liu, Xinrong Wang, Heshui Wu, Chunyou Wang, Ping Han, Siqi Wang. Pancreatic Ductal Adenocarcinoma at CT: A Combined Nomogram Model to Preoperatively Predict Cancer Stage and Survival Outcome. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.594510
|
| 3 |
Kun Jiang, Elaine Tan, Zena Sayegh, Barbara Centeno, Mokenge Malafa, Domenico Coppola. Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 2017; 25(9): 620 doi: 10.1097/PAI.0000000000000368
|
| 4 |
Atsushi Oba, Daisuke Ban, Susumu Kirimura, Keiichi Akahoshi, Yusuke Mitsunori, Satoshi Matsumura, Takanori Ochiai, Atsushi Kudo, Shinji Tanaka, Tanabe Minoru. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2016; 23(8): 480 doi: 10.1002/jhbp.366
|
| 5 |
Atsushi Oba, Daisuke Ban, Atsushi Kudo, Susumu Kirimura, Hiromitsu Ito, Satoshi Matsumura, Yusuke Mitsunori, Arihiro Aihara, Takanori Ochiai, Shinji Tanaka, Minoru Tanabe. Correlation Between the Acquisition of Resistance to Gemcitabine Therapy and the Expression of HuR in Pancreatic Ductal Adenocarcinoma: A Case Report. International Surgery 2018; 103(1-2): 116 doi: 10.9738/INTSURG-D-15-00278.1
|
| 6 |
Sari F Alhasan, Beate Haugk, Laura F Ogle, Gary S Beale, Anna Long, Alastair D Burt, Dina Tiniakos, Despina Televantou, Fareeda Coxon, David R Newell, Richard Charnley, Helen L Reeves. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma. British Journal of Cancer 2016; 115(7): 797 doi: 10.1038/bjc.2016.264
|